EMITF
Price
$2.01
Change
+$0.26 (+14.86%)
Updated
Jun 25 closing price
Capitalization
11.9M
NUWE
Price
$0.20
Change
-$0.02 (-9.09%)
Updated
Jul 3 closing price
Capitalization
2.42M
Interact to see
Advertisement

EMITF vs NUWE

Header iconEMITF vs NUWE Comparison
Open Charts EMITF vs NUWEBanner chart's image
Elbit Imaging
Price$2.01
Change+$0.26 (+14.86%)
Volume$3.1K
Capitalization11.9M
Nuwellis
Price$0.20
Change-$0.02 (-9.09%)
Volume$2.25M
Capitalization2.42M
EMITF vs NUWE Comparison Chart in %
Loading...
EMITF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EMITF vs. NUWE commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMITF is a Hold and NUWE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (NUWE: $0.20)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUWE’s FA Score shows that 0 FA rating(s) are green while.

  • NUWE’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EMITF’s TA Score shows that 5 TA indicator(s) are bullish while NUWE’s TA Score has 4 bullish TA indicator(s).

  • EMITF’s TA Score: 5 bullish, 2 bearish.
  • NUWE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, EMITF is a better buy in the short-term than NUWE.

Price Growth

NUWE (@Medical Specialties) experienced а -23.91% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EMITF($11.9M) has a higher market cap than NUWE($2.42M). EMITF YTD gains are higher at: 34.000 vs. NUWE (-82.315). EMITF has higher annual earnings (EBITDA): -294K vs. NUWE (-16.36M). NUWE has higher revenues than EMITF: NUWE (8.86M) vs EMITF (0).
EMITFNUWEEMITF / NUWE
Capitalization11.9M2.42M492%
EBITDA-294K-16.36M2%
Gain YTD34.000-82.315-41%
P/E RatioN/A0.02-
Revenue08.86M-
Total CashN/A3.8M-
Total DebtN/A760K-
FUNDAMENTALS RATINGS
EMITF vs NUWE: Fundamental Ratings
EMITF
NUWE
OUTLOOK RATING
1..100
9488
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
53
Fair valued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
90100
PRICE GROWTH RATING
1..100
4198
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EMITF's Valuation (23) in the Real Estate Development industry is in the same range as NUWE (53) in the Medical Specialties industry. This means that EMITF’s stock grew similarly to NUWE’s over the last 12 months.

EMITF's Profit vs Risk Rating (56) in the Real Estate Development industry is somewhat better than the same rating for NUWE (100) in the Medical Specialties industry. This means that EMITF’s stock grew somewhat faster than NUWE’s over the last 12 months.

EMITF's SMR Rating (90) in the Real Estate Development industry is in the same range as NUWE (100) in the Medical Specialties industry. This means that EMITF’s stock grew similarly to NUWE’s over the last 12 months.

EMITF's Price Growth Rating (41) in the Real Estate Development industry is somewhat better than the same rating for NUWE (98) in the Medical Specialties industry. This means that EMITF’s stock grew somewhat faster than NUWE’s over the last 12 months.

EMITF's P/E Growth Rating (100) in the Real Estate Development industry is in the same range as NUWE (100) in the Medical Specialties industry. This means that EMITF’s stock grew similarly to NUWE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EMITFNUWE
RSI
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EMITF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUWE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSLOY16.800.05
+0.30%
Mitsui O.S.K. Lines Ltd.
DIISF4.17N/A
N/A
Direct Line Insurance Group PLC
CHMX5.37N/A
N/A
Next-ChemX Corporation
APLO40.68N/A
N/A
Apollo Bancorp, Inc.
AILIM73.55N/A
N/A
Ameren Illinois Company

EMITF and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMITF has been loosely correlated with STSS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EMITF jumps, then STSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMITF
1D Price
Change %
EMITF100%
N/A
STSS - EMITF
38%
Loosely correlated
+1.75%
AVHHL - EMITF
26%
Poorly correlated
N/A
GCTK - EMITF
22%
Poorly correlated
+1.38%
NUWE - EMITF
22%
Poorly correlated
-10.57%
EMBC - EMITF
21%
Poorly correlated
+0.68%
More

NUWE and

Correlation & Price change

A.I.dvisor tells us that NUWE and PRE have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NUWE and PRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUWE
1D Price
Change %
NUWE100%
-10.57%
PRE - NUWE
24%
Poorly correlated
+1.14%
TMDX - NUWE
23%
Poorly correlated
+1.17%
HBIO - NUWE
23%
Poorly correlated
-3.51%
CRL - NUWE
22%
Poorly correlated
-0.23%
EMITF - NUWE
22%
Poorly correlated
N/A
More